These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 17928940

  • 1. The effect of insulin glargine and nutritional model on metabolic control, quality of life and behavior in children and adolescents with type 1 diabetes mellitus.
    Goksen D, Darcan S, Buyukinan M, Köse T, Erermis S, Coker M.
    Acta Diabetol; 2008 Mar; 45(1):47-52. PubMed ID: 17928940
    [Abstract] [Full Text] [Related]

  • 2. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M, Tapanainen P, Veijola R.
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [Abstract] [Full Text] [Related]

  • 3. The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes.
    Júlíusson PB, Graue M, Wentzel-Larsen T, Søvik O.
    Acta Paediatr; 2006 Nov; 95(11):1481-7. PubMed ID: 17062481
    [Abstract] [Full Text] [Related]

  • 4. Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes.
    Vinik AI, Zhang Q.
    Diabetes Care; 2007 Apr; 30(4):795-800. PubMed ID: 17259481
    [Abstract] [Full Text] [Related]

  • 5. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [Abstract] [Full Text] [Related]

  • 6. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K, Rodriguez LM, Johnson SE, Tadlock S, Heptulla RA.
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [Abstract] [Full Text] [Related]

  • 7. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M.
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [Abstract] [Full Text] [Related]

  • 8. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T.
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [Abstract] [Full Text] [Related]

  • 9. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L, Fredericks EM, Burkhart N, Dale L, Hodge M, Foster C.
    Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
    [Abstract] [Full Text] [Related]

  • 10. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.
    O'Neil KJ, Jonnalagadda SS, Hopkins BL, Kicklighter JR.
    J Am Diet Assoc; 2005 Jan; 105(1):85-91. PubMed ID: 15635351
    [Abstract] [Full Text] [Related]

  • 11. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.
    Bradley C, Gilbride CJ.
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():50-65. PubMed ID: 18577157
    [Abstract] [Full Text] [Related]

  • 12. Insulin glargine maintains equivalent glycemic control and better lipometabolic control than NPH insulin in type 1 diabetes patients who missed a meal.
    Rosak C, Jung R, Hofmann U.
    Horm Metab Res; 2008 Aug; 40(8):544-8. PubMed ID: 18493882
    [Abstract] [Full Text] [Related]

  • 13. [Management of children and adolescents with diabetes mellitus: personal experience].
    Dorchy H.
    Rev Med Brux; 2005 Sep; 26(4):S246-54. PubMed ID: 16240870
    [Abstract] [Full Text] [Related]

  • 14. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    EQuality1 Study Group--Evaluation of QUALITY of Life and Costs in Diabetes Type 1, Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F, Bruttomesso D, Di Bartolo P, Girelli A, Leonetti F, Morviducci L, Ponzi P, Vitacolonna E.
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [Abstract] [Full Text] [Related]

  • 15. Preliminary data of insulin glargine use among Thai adolescents and young adults with type 1 diabetes mellitus treated at Siriraj Hospital.
    Sawathiparnich P, Kiattisakthavee P, Santiprabhob J, Likitmaskul S.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S48-52. PubMed ID: 16856426
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of glargine group-start sessions in patients with type 2 diabetes as a strategy to deliver the service.
    Tahrani AA, Digwood S, Lee C, Moulik P.
    Int J Clin Pract; 2007 Feb; 61(2):329-35. PubMed ID: 17263721
    [Abstract] [Full Text] [Related]

  • 17. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K, Dornhorst A, Sreenan S.
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [Abstract] [Full Text] [Related]

  • 18. Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus.
    Fiallo-Scharer R, Horner B, McFann K, Walravens P, Chase HP.
    J Pediatr; 2006 Apr; 148(4):481-4. PubMed ID: 16647408
    [Abstract] [Full Text] [Related]

  • 19. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW.
    Clin Ther; 2007 Apr; 29 Suppl D():S135-44. PubMed ID: 18191065
    [Abstract] [Full Text] [Related]

  • 20. Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.
    Knerr I, Hofer SE, Holterhus PM, Näke A, Rosenbauer J, Weitzel D, Wolf J, Holl RW.
    Diabet Med; 2007 Dec; 24(12):1478-81. PubMed ID: 17971184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.